This podcast focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The podcast also includes case discussions.
This activity is supported by an unrestricted educational grant from Aerie.
Upon completion of this activity, the participant should be able to:
This podcast has no credit associated with it.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Ian Benjamin Gaddie, OD, FAAO, and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: Aerie. Consultant and Speakers Bureau: Allergan Novartis, Aerie, Bausch, Zeiss, Invantis, and Sight Sciences. Stock holder: Tarsus and Leo Lens.
Gagan Sawhney, MD and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, and New World Medical.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Aerie.
By: Ian Benjamin Gaddie, OD, FAAO; and Gagan Sawhney, MD